Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in the Elderly
NCT00451113Phase 2Completed
- Sponsor
- University of British Columbia
- Start
- Nov 2006
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of British Columbia. Primary endpoint: Safety and efficacy of Sitagliptin in an elderly population with type 2 diabetes. Started Nov 2006; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00451113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451113.